首页> 外国专利> Combination preparation containing nucleoside compound and 5-sulfonyl-2-phenylacetamido-thiazole derivative, useful as antiviral agent effective againts herpes viruses, especially herpes simplex

Combination preparation containing nucleoside compound and 5-sulfonyl-2-phenylacetamido-thiazole derivative, useful as antiviral agent effective againts herpes viruses, especially herpes simplex

机译:含有核苷化合物和5-磺酰基-2-苯基乙酰氨基-噻唑衍生物的组合制剂,可用作抗病毒剂,能有效地治疗疱疹病毒,特别是单纯疱疹

摘要

New combination preparations (A) contain (a) nucleoside compounds (specifically acyclovir or penciclovir) and (b) 5-aminosulfonyl-2-phenylacetamido-thiazole derivatives (I) or 5-halosulfonyl-2-phenylacetamido-thiazole derivatives (IV). New combination preparations (A) contain nucleoside compounds (specifically acyclovir, penciclovir or their prodrugs) and (b) thiazole derivatives of formula (I) (or their salts) or (IV). R1 = H, halo, alkyl, alkoxy, aminoalkyl or haloalkyl; R2, R3 = H, alkoxy, cycloalkyl or biphenylaminocarbonyl; alkyl (optionally substituted (os) by 1-3 of 3-6C cycloalkyl, alkoxy, halo, OH, NH2, trialkylsilyloxy, 3,4-methylenedioxyphenyl, tetrahydrofuran-2-yl, -N(R'2)COOtBu, Het1, Het2 or aryl (os by OH or alkoxy)); -P(O)(OR8)(OR9), -COCH(NH2)-R10, -CHR11-OCOR12 or -CH(NH2)-R10; or NR2R3 = 5- or 6-membered saturated heterocycle, optionally containing a further O heteroatom; R'2, R8, R9 = H or 1-4C alkyl; Het1 = C- or N-bonded 5- or 6-membered aromatic heterocycle containing 1-3 of S, N and/or O as heteroatom(s)); Het2 = C- or N-bonded 3-8 membered, saturated or unsaturated, non-aromatic heterocycle containing 1-3 of S, N and/or O as heteroatom(s)); R10 = side-chain of a naturally occurring aminoacid; R11 = 1-4C alkyl; R12 = H, 1-4C alkyl or -CH(NH2)-R10; R4 = H, acyl, 2-6C alkenyl or cycloalkyl; or alkyl (os by 1-3 of halo, OH, cycloalkyl, acyl, alkoxy, COOH, NHCOOtBu, OEt, -CH2CH2OEt, phenoxy, aryl or NR13R14); or alkyl substituted by optionally benzo-fused Het1, 2-(R16)-pyrrolidino, tetrahydrofuran-2-yl, benzo-1,4-dioxan-2-yl, 2-oxo-pyrrolidino or -OCOR17R18; R13, R14 = H, acyl, alkyl, CONH2, mono- or dialkylaminoalkyl, mono- or dialkylaminocarbonyl, aryl or alkoxycarbonyl; or NR13R14 = 5- or 6-membered saturated heterocyclyl, optionally containing a further O, S or NR15 heteroatom and os by =O; R15 = H or 1-4C alkyl; R16 = H or alkyl; R17, R18 = H; or alkyl or aryl (both os by 1-3 of OH, alkoxy or halo); R5, R7 = H, alkyl, halo, NH2, mono- or dialkylamino or alkanoylamino; R6 = phenyl (os by 1-3 groups R'6); R'6 = halo, aryl (os by 1-3 of alkanoyl, alkoxy, alkyl, halo, alkoxycarbonyl, NO2, haloalkyl, haloalkoxy, NH2, alkylthio, OH, COOH, CONH2, mono- or dialkylaminocarbonyl, mono- or dialkanoylamino, alkoxycarbonylamino, alkylsulfoxy, alkylsulfonyl, trialkylsilyloxy, Het2 or CN), alkoxy (os by 1-6 F, but not perfluorinated), alkoxycarbonyl, alkylthio, OH, COOH, alkyl (os by tetrahydrofuran-2-yl), Het1 (os by 1-3 of alkanoyl, alkoxy, alkyl, halo, alkoxycarbonyl, NO2, haloalkyl, haloalkoxy, NH2, alkylthio, OH, COOH, CONH2, mono- or dialkylaminocarbonyl, mono- or dialkanoylamino, alkoxycarbonylamino, alkylsulfoxy, alkylsulfonyl, Het2 (mono- or bicyclic) or CN), Het2 (mono- or bicyclic; and os by 1-3 of =O, halo, OH, alkoxycarbonyl, alkoxycarbonylamino, alkyl, haloalkyl or hydroxyalkyl), 2-6C alkenyl, OR19, NR20R21, CONR22R23, carbazole, dibenzofuran, dibenzothiophene, xanthene or 9,10-dihydroacridine; R19 = phenyl (os by NR24R25) or alkyl (os by 1-3 of OH or halo); R24, R25 = H, alkyl or acyl; R20, R21 = H, CONH2, mono- or dialkylaminocarbonyl, phenyl, acyl or alkyl (os by alkoxy or acyl; or by phenyl or Het1 (both os by 1-3 of halo or OH)); R22, R23 = H or alkyl; D = halogen; alkyl moieties or acyl groups have 1-6C, cycloalkyl moieties 3-8C and aryl moieties 6-10C unless specified otherwise.
机译:新的组合制剂(A)含有(a)核苷化合物(特别是阿昔洛韦或喷昔洛韦)和(b)5-氨基磺酰基-2-苯基乙酰氨基-噻唑衍生物(I)或5-卤磺酰基-2-苯基乙酰氨基-噻唑衍生物(IV)。新的组合制剂(A)含有核苷化合物(特别是阿昔洛韦,喷昔洛韦或其前药)和(b)式(I)的噻唑衍生物(或其盐)或(IV)。 R1 = H,卤素,烷基,烷氧基,氨基烷基或卤代烷基; R2,R3 = H,烷氧基,环烷基或联苯氨基羰基;烷基(可选地被3-6C环烷基,烷氧基,卤素,OH,NH2,三烷基甲硅烷基氧基,3,4-亚甲基二氧基苯基,四氢呋喃-2-基,-N(R'2)COOtBu,Het1, Het2或芳基(被OH或烷氧基取代); -P(O)(OR8)(OR9),-COCH(NH2)-R10,-CHR11-OCOR12或-CH(NH2)-R10;或NR 2 R 3 = 5或6元饱和杂环,任选地包含另外的O杂原子;或R′2,R8,R9 = H或1-4C烷基; Het1 =含有1-3个S,N和/或O作为杂原子的C或N键结合的5或6元芳族杂环); Het2 =含有1-3个S,N和/或O作为杂原子的C键或N键键合的3-8元饱和或不饱和非芳族杂环); R10 =天然存在的氨基酸的侧链; R11 = 1-4C烷基; R12 = H,1-4C烷基或-CH(NH2)-R10; R4 = H,酰基,2-6C烯基或环烷基;或烷基(卤素,OH,环烷基,酰基,烷氧基,COOH,NHCOOOtBu,OEt,-CH2CH2OEt,苯氧基,芳基或NR13R14的1-3);或被任选地苯并稠合的Het1、2-(R16)-吡咯烷基,四氢呋喃-2-基,苯并-1,4-二恶烷-2-基,2-氧代吡咯烷基或-OCOR17R18取代的烷基;或R13,R14 = H,酰基,烷基,CONH2,单或二烷基氨基烷基,单或二烷基氨基羰基,芳基或烷氧羰基;或NR 13 R 14 = 5或6元饱和杂环基,任选地包含另外的O,S或NR 15杂原子和os,= O;或R15 = H或1-4C烷基; R16 = H或烷基; R17,R18 = H;或烷基或芳基(两者均为OH的1-3,烷氧基或卤素); R5,R7 = H,烷基,卤素,NH2,单或二烷基氨基或烷酰基氨基; R6 =苯基(由1-3个R′6基团组成的os); R'6 =卤代,芳基(烷酰基,烷氧基,烷基,卤素,烷氧基羰基,NO2,卤代烷基,卤代烷氧基,NH2,烷硫基,OH,COOH,CONH2、1-3的单或二烷基氨基羰基,单或二烷酰基氨基,烷氧基羰基氨基,烷基亚磺氧基,烷基磺酰基,三烷基甲硅烷基氧基,Het2或CN),烷氧基(os在1-6 F下但未全氟化),烷氧基羰基,烷硫基,OH,COOH,烷基(os在四氢呋喃-2-基上),Het1(os在1-3的烷酰基,烷氧基,烷基,卤素,烷氧基羰基,NO2,卤代烷基,卤代烷氧基,NH2,烷硫基,OH,COOH,CONH2,单或二烷氨基羰基,单或二烷酰基氨基,烷氧基羰基氨基,烷基磺氧基,烷基磺酰基,Het2(单-或CN),Het2(单环或双环;且os的1-3为= O,卤素,OH,烷氧羰基,烷氧羰基氨基,烷基,卤代烷基或羟烷基),2-6C烯基,OR19,NR20R21,CONR22R23,咔唑,二苯并呋喃,二苯并噻吩,x吨或9,10-二氢ac啶; R19 =苯基(NR24R25为os)或烷基(OH或卤素为1-3的os); R24,R25 = H,烷基或酰基; R20,R21 = H,CONH2,单或二烷基氨基羰基,苯基,酰基或烷基(通过烷氧基或酰基的os;或通过苯基或Het1(两者均为卤素或OH的1-3)); R22,R23 = H或烷基; D =卤素;除非另有说明,否则烷基部分或酰基具有1-6C,环烷基部分3-8C和芳基部分6-10C。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号